ADVERTISEMENT

Sleepless and paranoid

Current Psychiatry. 2013 April;12(04):39-43
Author and Disclosure Information

Mr. Q, age 44, presents with disorientation, paranoid delusions, and auditory and visual hallucinations that began after his sleep started to deteriorate 6 months ago. What could be causing his insomnia?

12

Table 3

DSM-IV-TR diagnostic criteria for opioid withdrawal

A. Either of the following:
  1. Cessation of (or reduction in) opioid use that has been heavy and prolonged (several weeks or longer)
  2. Administration of an opioid antagonist after a period of opioid use
B. ≥3 of the following, developing within minutes to several days after criterion A:
  1. dysphoric mood
  2. nausea or vomiting
  3. muscle aches
  4. lacrimation or rhinorrhea
  5. pupillary dilation, piloerection, or sweating
  6. diarrhea
  7. yawning
  8. fever
  9. insomnia
C.The symptoms of criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning
D.The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder
Source: Reference 11
Related Resources
  • Morin CM, Benca R. Chronic insomnia. Lancet. 2012; 379(9821):1129-1141.
  • Pressman MR, Orr WC, eds. Understanding sleep: the evolution and treatment of sleep disorders. Washington, DC: American Psychological Association; 1997.
  • NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements. 2005;22(2):1-30.
Drug Brand Names
  • Albuterol • Proventil, Ventolin
  • Aripiprazole • Abilify
  • Bupropion • Wellbutrin, Zyban
  • Dextroamphetamine • Dexadrine
  • Haloperidol • Haldol
  • Hydrocodone/Acetaminophen • Vicodin
  • Lamotrigine • Lamictal
  • Lorazepam • Ativan
  • Methylphenidate • Methylin, Ritalin
  • Phenylephrine • Neo-Synephrine
  • Pseudoephedrine • Sudafed
  • Ramelteon • Rozerem
  • Theophylline • Elixophyllin, Slo-Phyllin
  • Zolpidem • Ambien
Disclosure

The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.